Illumina last week announced the appointments of Elizabeth Brady as VP of global supply chain, and Emily Winn-Deen as VP of diagnostics development.
Brady will report to William Bonnar, senior VP of Illumina's operations. Prior to joining Illumina, Brady was VP of global supply chain at Boston Scientific's cardiac rhythm management division.
Winn-Deen will report to Gregory Heath, Illumina's VP of diagnostics. She previously served as president of the consulting practice Rx Dx Advisors, and held leadership positions at Cepheid.
As incentives to join the company, Brady was granted the option to purchase 120,000 shares of Illumina's common stock and Winn-Deen received an option to purchase 112,000 shares. The grant date for the option to Brady is May 3, and April 26 for Winn-Deen.
Canada-based molecular diagnostics firm GeneNews announced the appointment of Leslie Auld as its new chief financial officer and treasurer, effective May 3.
Prior to joining GeneNews, Auld held various leadership positions at PricewaterhouseCoopers, Helix BioPharma, Luminex Diagnostics, and Attwell Capital.
Auld succeeds Sonny Young who since January has held the interim position of VP of finance and treasurer. Young will continue to work for GeneNews as a consultant.